PPARA and metabolic syndrome: PPARα regulates the expression of a number of genes critical for lipid and lipoprotein metabolism, and PPARα ligand fibrates are used for the treatment of dyslipidemia due to their ability to lower plasma triglyceride levels and elevate HDL cholesterol levels.